Why is Kilitch Drugs falling/rising?

As of 19-Aug, Kilitch Drugs (India) Ltd is experiencing a decline in its stock price, currently at 415.15, which reflects a decrease of 8.45 or 1.99%. The stock has been underperforming, having fallen consecutively for the last four days, resulting in a total decline of 7.74% over the past week. Today's trading has shown no range, with the stock opening and trading at the same price. Additionally, the stock's delivery volume has decreased significantly, down by 84.42% compared to the 5-day average, indicating falling investor participation. Despite a healthy long-term growth trajectory, with net sales increasing at an annual rate of 31.41% and consistent returns over the last three years, the recent performance has been negatively impacted by these short-term trends.
In the broader market context, Kilitch Drugs has underperformed against the benchmark, the Sensex, which has gained 1.76% over the past week. While the stock has shown strong year-to-date growth of 28.53% compared to the Sensex's 4.49%, its recent short-term performance contrasts sharply with this long-term success. The stock's current price movement and declining returns highlight a disconnect between its historical performance and recent market sentiment, suggesting that investors may be reacting to short-term volatility rather than the company's solid fundamentals.